Novartis reported CHF54.04B in Equity Capital and Reserves for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Amgen AMGN:US $ 8247M 1087M
AstraZeneca AZN:LN 15676M 1246M
Bayer BAYN:GR € 30389M 4199M
Biogen BIIB:US $ 10751.9M 69.7M
Bristol Myers Squibb BMY:US $ 36808M 797M
Eli Lilly And LLY:US $ 6444.4M 454.3M
Fresenius FRE:GR € 17699M 108M
Fresenius Medical Care FME:GR € 12812M 388M
Galapagos GLPG:NA € 2663.47M 37.99M
Genmab GEN:DC DK 20252M 157M
Gilead Sciences GILD:US $ 19710M 758M
GlaxoSmithKline GSK:LN 15377M 512M
GRIFOLS GRF:SM € 5168.17M 254.92M
H. Lundbeck A/S LUN:DC 17.54B 317M
Hikma Pharmaceutical HIK:LN 2.29B 155M
Lonza Group LONN:SW 7.27B 452M
Merck MRK:GR € 19293M 377M
Novartis NOVN:VX SF 54042M 3519M
Novartis NVS:US $ 54042M 3519M
Orion ORNBV:FH € 698.5M 69.6M
Philips PHIA:NA € 11953M 540M
Recordati REC:IM € 1328.09M 0.69M
Regeneron Pharmaceuticals REGN:US $ 15127.3M 3150.3M